Last edition
News about "Hypertension Drug"
AstraZeneca Wins US Approval for Baxfendy, First Aldosterone Synthase Inhibitor for Hypertension
AstraZeneca receives US approval for Baxfendy, the first Aldosterone Synthase Inhibitor (ASI) for adults with hypertension, supported by phase 3 BaxHTN trial results showing significant reductions in systolic blood pressure.
Hypertension Drug | 20/05/2026 | By News Bureau
Zydus Pharma Secures USFDA Approval for Generic Hypertension Drug
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration to market Telmisartan tablets, a generic version of a commonly prescribed blood pressure medication.
Hypertension Drug | 26/11/2025 | By Darshana | 330
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy